Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.
Marcello Solinas, Steven R Goldberg
Psychopharmacology June 2005 DOI: 10.1007/s00213-004-2118-x (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Drug-discrimination study in rats Peer reviewed |
|---|---|
| Population | Rats trained to discriminate 3 mg/kg i.p. THC from vehicle |
| Interventions | delta-9-tetrahydrocannabinol (THC) heroin SNC-80 U50488 naltrexone naltrindole |
| Dose | THC 3 mg/kg i.p.; heroin 0.3-1.0 mg/kg i.p.; SNC-80 1-10 mg/kg i.p.; U50488 1-10 mg/kg i.p.; naltrexone 0.1-1 mg/kg i.p.; naltrindole 1-10 mg/kg i.p.; nor-binaltorphimine 5 mg/kg s.c. |
| Topics | Cannabis |
| Key points | The mu-opioid receptor appears to be involved in the discriminative-stimulus effects of THC, whereas delta- and kappa-opioid receptors do not. Heroin shifted the THC dose-response curve leftward and naltrexone shifted it rightward and blocked heroin's effect, while SNC-80, U50488, naltrindole, and nor-binaltorphimine did not. The authors suggest that THC's discriminative and rewarding effects may share similar neural mechanisms. |
Abstract
Many behavioral effects of delta-9-tetrahydrocannabinol (THC), including its discriminative-stimulus effects, are modulated by endogenous opioid systems. To investigate opioid receptor subtypes involved in the discriminative effects of THC. Rats trained to discriminate 3 mg/kg i.p. of THC from vehicle using a two-lever operant drug-discrimination procedure, were tested with compounds that bind preferentially or selectively to either mu-, delta- or kappa-opioid receptors. The preferential mu-opioid receptor agonist heroin (0.3-1.0 mg/kg, i.p.), the selective delta-opioid receptor agonist SNC-80 (1-10 mg/kg, i.p.) and the selective kappa-opioid receptor agonist U50488 (1-10 mg/kg, i.p.) did not produce generalization to the discriminative effects of THC when given alone. However, heroin, but not SNC-80 or U50488, significantly shifted the dose-response curve for THC discrimination to the left. Also, the preferential mu-opioid receptor antagonist naltrexone (0.1-1 mg/kg, i.p.), the selective delta-opioid receptor antagonist, naltrindole (1-10 mg/kg, i.p.) and the kappa-opioid receptor antagonist nor-binaltorphimine (n-BNI, 5 mg/kg, s.c.), did not significantly reduce the discriminative effects of the training dose of THC. However, naltrexone, but not naltrindole or n-BNI, significantly shifted the dose-response curve for THC discrimination to the right. Finally, naltrexone, but not naltrindole or n-BNI, blocked the leftward shift in the dose-response curve for THC discrimination produced by heroin. mu- but not delta- or kappa-opioid receptors are involved in the discriminative effects of THC. Given the role that mu-opioid receptors play in THC's rewarding effects, the present findings suggest that discriminative-stimulus effects and rewarding effects of THC involve similar neural mechanisms.
Comparable studies
Other preclinical and animal studies on cannabis, most cited first.
Citations in the library
Cited by 16
- Sex and Gender Differences in the Effects of Novel Psychoactive Substances. Brain Sciences September 3, 2020
- “Hallucinations” Following Acute Cannabis Dosing: A Case Report and Comparison to Other Hallucinogenic Drugs Cannabis and Cannabinoid Research April 2, 2018
- Differential effects of serotonin 5-HT1A receptor agonists on the discriminative stimulus effects of the 5-HT2A receptor agonist 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rats and rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics April 1, 2010
- Repeated administration of the synthetic cannabinoid AKB48 induces serotonergic neuroadaptation in male and female mice: behavioural and immunohistochemical evidence. Neuropharmacology February 1, 2026
- Discriminative stimulus properties of 3-substituent rimonabant analogs VCU Scholars Compass 2011
and 11 more in the library
Cites 5
- Absence of delta -9-tetrahydrocannabinol dysphoric effects in dynorphin-deficient mice. Journal of Neuroscience December 1, 2001
- Cannabis: discrimination of "internal bliss"? Pharmacology, Biochemistry, and Behavior October 1999
- The effects of cannabinoids on the brain. Progress in Neurobiology July 1999
- Pharmacological specificity of delta 9-tetrahydrocannabinol discrimination in rats. Psychopharmacology April 1995
- Evidence for separate neuronal mechanisms for the discriminative stimulus and catalepsy induced by delta 9-THC in the rat. Psychopharmacology 1992